bioAffinity Technologies, Inc. (BIAF) Form 10-Q Quarterly Reports
bioAffinity Technologies, Inc. (BIAF) is a publicly traded company on the Nasdaq, categorized under SIC 8731 (Services-Commercial Physical & Biological Research). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BIAF
CIK: 1712762
Exchange: Nasdaq
SIC 8731: Services-Commercial Physical & Biological Research
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
WithumSmith+Brown, PC
Auditor SinceSince 12/31/2021 12:00:00 AM
Lead Engagement PartnerMarc Silverman
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | 8-K | 0001493152-26-047168 | View SEC Doc Filr Page |
| 8-K | 2026-10-13 | 2026-10-13 | 8-K | 0001493152-26-046755 | View SEC Doc Filr Page |
| PRER14A | 2026-10-13 | — | PRER14A | 0001493152-26-046675 | View SEC Doc Filr Page |
| 8-K | 2026-10-09 | 2026-10-08 | 8-K | 0001493152-26-046548 | View SEC Doc Filr Page |
| 424B5 | 2026-10-09 | — | 424B5 | 0001493152-26-046454 | View SEC Doc Filr Page |
| 424B5 | 2026-10-09 | — | 424B5 | 0001493152-26-046449 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-08 | 8-K | 0001493152-26-046266 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-10-06 | 8-K | 0001493152-26-045867 | View SEC Doc Filr Page |
| 8-K | 2026-09-30 | 2026-09-30 | 8-K | 0001493152-26-045034 | View SEC Doc Filr Page |
| PRE 14A | 2026-09-29 | 2026-09-29 | PRE 14A | 0001493152-26-044815 | View SEC Doc Filr Page |
| 8-K | 2026-09-22 | 2026-09-22 | 8-K | 0001493152-26-043654 | View SEC Doc Filr Page |
| 8-K | 2026-09-17 | 2026-09-17 | 8-K | 0001493152-26-043052 | View SEC Doc Filr Page |
| 8-K | 2026-09-11 | 2026-09-11 | 8-K | 0001493152-26-042304 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-08 | 8-K | 0001493152-26-041894 | View SEC Doc Filr Page |
| 424B3 | 2026-09-08 | — | 424B3 | 0001493152-26-041786 | View SEC Doc Filr Page |
| EFFECT | 2026-09-04 | — | EFFECT Filing | 9999999995-26-002900 | View SEC Doc Filr Page |
| 8-K | 2026-09-03 | 2026-09-03 | 8-K | 0001493152-26-041387 | View SEC Doc Filr Page |
| S-3/A | 2026-09-03 | — | S-3/A | 0001493152-26-041354 | View SEC Doc Filr Page |
| 8-K | 2026-09-01 | 2026-09-01 | 8-K | 0001493152-26-041020 | View SEC Doc Filr Page |
| S-3 | 2026-08-27 | — | S-3 | 0001493152-26-040412 | View SEC Doc Filr Page |
| 8-K | 2026-08-20 | 2026-08-20 | 8-K | 0001493152-26-039375 | View SEC Doc Filr Page |
| 8-K | 2026-08-18 | 2026-08-18 | 8-K | 0001493152-26-038897 | View SEC Doc Filr Page |
| 8-K | 2026-08-14 | 2026-08-12 | 8-K | 0001493152-26-038437 | View SEC Doc Filr Page |
| 10-Q | 2026-08-07 | 2026-06-30 | 10-Q | 0001493152-26-036619 | View SEC Doc Filr Page |
| 8-K | 2026-08-07 | 2026-08-07 | 8-K | 0001493152-26-036486 | View SEC Doc Filr Page |